AI-generated summary and notes. Check quotations, numbers, and important claims against the source video. Captions may contain errors.
Watch the source video on YouTube
Estimated reading time: 38 minutes for the text on this page.
In this episode, Adam Fayed features Louisa Clouder, founder of Fenchurch Legal, who shares her journey from Greece to the UK, eventually venturing into litigation financeβa growing multi-billion-dollar industry. Louisa explains how the COVID-19 lockdown unexpectedly benefited the launch of her business and how litigation finance opens access to justice for those unable to afford legal action. She discusses the various case types funded by Fenchurch Legal and how they mitigate risks for investors, aiming to double their loan book in the near future while expanding their tech capabilities. Louisa concludes by highlighting the opportunities and ethical considerations in this booming industry.
Louisa Clouder founded Fenchurch Legal after spotting a gap in the litigation finance market. With roots in Greece and a robust career in corporate finance in the UK, she utilized her experience to launch the company during the COVID-19 pandemic. The lockdown surprisingly facilitated the business's inception, with people more open to remote interactions.
Fenchurch Legal focuses on financing litigation cases, especially small claims involving personal injury or financial mismanagement. By doing so, it provides individuals the means to seek justice without financial burdens. Amidst the pandemic, Louisa's company thrived, generating over 42 million in business and planning to double this figure in the coming years.
The growth of Fenchurch Legal is buoyed by careful risk management and strategic investor engagement. With a significant base of high-net-worth expat investors, the company ensures stringent underwriting and full-spectrum security measures to protect loans. As alternatives become attractive to investors, Fenchurch Legal continues to innovate with tech advancements, including a new AI audit system.